We use up to date technology and research-based practices to guide surveillance and early identification and treatment for lymphoedema. 

Factors that increase the risk of developing lymphoedema following treatment for cancer include:

·      surgery with lymph nodes removed

·      radiotherapy and chemotherapy treatments

·      being overweight

·      infection

·      immobility

These factors do not mean you will get lymphoedema. However, careful monitoring and early detection can help prevent or limit the progress of this condition.

We take pre-treatment measurements to record your body’s usual baseline measurements.

Measurements include:

1.     Weight & height

2.     Circumferential measures of both arms (tape measure)

3.     Lymphoedema Index (or L- Dex) is a simple, painless test which detects the amount of fluid in a limb.

We advise repeating these measurements at three to six monthly intervals for the first two years after treatment.

All of our pre-treatment measurements are conducted by a fully qualified lymphoedema therapist and will take less than 30 minutes.

L-Dex (Bioimpedance)

 
L-dex.jpg

Early intervention improves treatment outcomes.

L-Dex measurement helps us identify sub-clinical arm or leg lymphoedema following surgery or cancer treatment. This means treatment can be started before you may notice a change. 

L-Dex can also be used to monitor lymphoedema over time and success of treatments.